Stockscreener 앱 받기
8.50
11.99%
0.91
시간 외 거래:
8.58
0.08
+0.94%
전일 마감가:
$7.59
열려 있는:
$7.57
하루 거래량:
2.43M
Relative Volume:
1.08
시가총액:
$1.47B
수익:
$25.55M
순이익/손실:
$-341.97M
주가수익비율:
-3.0357
EPS:
-2.8
순현금흐름:
$-304.44M
1주 성능:
+14.71%
1개월 성능:
-0.70%
6개월 성능:
+127.27%
1년 성능:
+80.08%
1일 변동 폭
$7.42
$8.635
1주일 범위
$7.36
$8.635
52주 변동 폭
$1.775
$9.04
릴레이 테라퓨틱스 Stock (RLAY) Company Profile
명칭
Relay Therapeutics Inc
전화
617-370-8837
주소
60 HAMPSHIRE STREET, CAMBRIDGE
RLAY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
8.50 | 1.32B | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
릴레이 테라퓨틱스 Stock (RLAY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-12 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-09-04 | 재개 | Guggenheim | Buy |
| 2025-04-17 | 개시 | Wells Fargo | Equal Weight |
| 2024-09-10 | 재개 | Goldman | Buy |
| 2024-09-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-09-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-05-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-04-20 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-04-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | 개시 | Raymond James | Outperform |
| 2023-02-03 | 개시 | Oppenheimer | Outperform |
| 2022-09-30 | 개시 | Barclays | Equal Weight |
| 2022-09-02 | 개시 | Stifel | Buy |
| 2022-06-06 | 개시 | Jefferies | Underperform |
| 2022-02-01 | 개시 | Berenberg | Buy |
| 2021-07-21 | 개시 | BofA Securities | Buy |
| 2020-12-15 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-08 | 개시 | JMP Securities | Mkt Outperform |
| 2020-11-05 | 개시 | H.C. Wainwright | Buy |
| 2020-08-10 | 개시 | Cowen | Outperform |
| 2020-08-10 | 개시 | Goldman | Buy |
| 2020-08-10 | 개시 | Guggenheim | Buy |
| 2020-08-10 | 개시 | JP Morgan | Neutral |
모두보기
릴레이 테라퓨틱스 주식(RLAY)의 최신 뉴스
Oppenheimer Upgrades Relay Therapeutics (RLAY) - Nasdaq
Oppenheimer Upgrades Relay Therapeutics (RLAY) with Positive Out - GuruFocus
Oppenheimer upgrades Relay Therapeutics stock rating on gedatolisib concerns By Investing.com - Investing.com Canada
Relay Therapeutics (RLAY) Upgraded by Oppenheimer, Price Target Set at $14.00 | RLAY Stock News - GuruFocus
Relay Therapeutics stock rises after Oppenheimer upgrade By Investing.com - Investing.com Nigeria
Relay Therapeutics stock rises after Oppenheimer upgrade - Investing.com
Oppenheimer Upgrades Relay Therapeutics to Outperform From Market Perform, Price Target is $14 - marketscreener.com
Dip Buying: Can Relay Therapeutics Inc expand into new markets2025 Biggest Moves & Long-Term Growth Stock Strategies - baoquankhu1.vn
Published on: 2026-01-24 18:03:27 - baoquankhu1.vn
Analyst Calls: Will Relay Therapeutics Inc. stock hit new highs in YEARSell Signal & Technical Confirmation Alerts - baoquankhu1.vn
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Performance Recap: Can Relay Therapeutics Inc keep up with sector leadersWeekly Trade Review & Growth Focused Entry Point Reports - baoquankhu1.vn
Decliners Report: Can Relay Therapeutics Inc sustain its profitabilityJuly 2025 Movers & Weekly Top Gainers Trade List - baoquankhu1.vn
Aug Intraday: Will Relay Therapeutics Inc stock hit new highs in YEAR2025 Technical Overview & Smart Swing Trading Alerts - baoquankhu1.vn
Relay Therapeutics, Inc. (RLAY) Stock Analysis: A Biotech Play with Potential 91% Upside Driven by Analyst Confidence - directorstalkinterviews.com
Guidance Update: How does FingerMotion Inc compare to its peersNew Guidance & Fast Moving Stock Watchlists - baoquankhu1.vn
Bearish Setup: What is the dividend yield of CPSSJuly 2025 Chart Watch & Fast Gaining Stock Reports - baoquankhu1.vn
Market Recap: Can Relay Therapeutics Inc keep up with sector leadersTrade Exit Report & Community Consensus Stock Picks - baoquankhu1.vn
Why Relay Therapeutics Inc. stock could outperform in 2025Footwear buying guidance for daily running and walking routines focuses on joint friendly cushioning, making it a solid option for daily use. - ulpravda.ru
Aug Reactions: Can Relay Therapeutics Inc keep up with sector leadersEarnings Overview Summary & Weekly High Potential Alerts - baoquankhu1.vn
Aug Levels: Is Relay Therapeutics Inc stock showing strong momentumMarket Rally & Technical Confirmation Trade Alerts - baoquankhu1.vn
Have Relay Therapeutics Insiders Been Selling Stock? - simplywall.st
Is Relay Therapeutics Inc. stock a contrarian buyDollar Strength & Real-Time Stock Movement Alerts - Улправда
Will Relay Therapeutics Inc. stock deliver shareholder valueTrade Entry Report & Technical Analysis for Trade Confirmation - Улправда
Will Relay Therapeutics Inc. stock benefit from sector rotationQuarterly Risk Review & Low Risk Profit Maximizing Plans - ulpravda.ru
Will Relay Therapeutics Inc. stock split attract more investors2025 Technical Overview & Consistent Income Trade Recommendations - Улправда
How strong is Relay Therapeutics Inc. stock balance sheetWeekly Volume Report & Daily Oversold Bounce Ideas - ulpravda.ru
Why Relay Therapeutics Inc. stock could benefit from AI revolutionWall Street Watch & Weekly High Conviction Trade Ideas - Улправда
How Relay Therapeutics Inc. stock performs in rate cut cyclesRisk Management & Low Drawdown Trading Techniques - ulpravda.ru
CEO Change: Will Relay Therapeutics Inc. stock pay special dividendsEarnings Recap Summary & Daily Entry Point Trade Alerts - ulpravda.ru
Is Relay Therapeutics Inc. stock a buy before product launchesEnergy Sector Updates & Free Professional Investment Consultations - Улправда
Insider Selling: Relay Therapeutics (NASDAQ:RLAY) CEO Sells $337,573.76 in Stock - MarketBeat
User | guymondailyherald.comRelay Therapeutics, Inc.Common Stock (Nasdaq:RLAY) Stock Quote - FinancialContent
Relay Therapeutics Q3 2025 Earnings Preview - MSN
Relay Therapeutics announces analysis of data for zovegalisib - MSN
What makes Relay Therapeutics Inc. stock attractive to growth funds2026 world cup usa national team round of 32 goalkeepers low block defense knockout prediction guide - ulpravda.ru
Relay Therapeutics CEO Sanjiv Patel sells $818,399 in stock - MSN
Relay Therapeutics, Inc. (RLAY) Stock Analysis: Unpacking the 72.58% Potential Upside in Precision Medicine - DirectorsTalk Interviews
Why Relay Therapeutics Stock Rocketed Nearly 15% Higher This Week - MSN
Aug Action: What makes Relay Therapeutics Inc. stock attractive to growth fundsPortfolio Value Report & Weekly High Conviction Trade Ideas - moha.gov.vn
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Take Profit: Can Relay Therapeutics Inc. stock hit record highs again2025 Valuation Update & Precise Trade Entry Recommendations - moha.gov.vn
Will Relay Therapeutics Inc. stock gain from strong economyFibonacci Retracement Levels & Analyze Your Portfolio Risk in Seconds - bollywoodhelpline.com
Relay Therapeutics (NASDAQ:RLAY) Shares Up 4.9%Here's What Happened - MarketBeat
Congress Asset Management Co. Has $2.13 Million Stock Holdings in Relay Therapeutics, Inc. $RLAY - MarketBeat
Relay Therapeutics signals slowdown to recharge after busy year - Traders Union
Will Relay Therapeutics Inc stock pay special dividendsMarket Sentiment Report & Verified Technical Signals - moha.gov.vn
Zovegalisib’s Consistent Efficacy Across Tough Subgroups Could Be A Game Changer For Relay (RLAY) - simplywall.st
What sentiment indicators say about Relay Therapeutics Inc. stockQuarterly Market Summary & High Win Rate Trade Alerts - Улправда
Can Relay Therapeutics Inc. stock hit analyst price targets2025 Sector Review & AI Enhanced Trading Alerts - Улправда
Is Relay Therapeutics Inc. stock attractive for passive investors2025 Biggest Moves & Risk Managed Investment Entry Signals - Улправда
릴레이 테라퓨틱스 (RLAY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
릴레이 테라퓨틱스 주식 (RLAY) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Patel Sanjiv | President and CEO |
Nov 03 '25 |
Sale |
7.00 |
62,073 |
434,511 |
703,215 |
| Rahmer Peter | See remarks |
Oct 29 '25 |
Sale |
7.50 |
21,394 |
160,455 |
337,469 |
| Rahmer Peter | See remarks |
Oct 28 '25 |
Sale |
7.29 |
19,135 |
139,494 |
358,863 |
| Catinazzo Thomas | Chief Financial Officer |
Oct 28 '25 |
Sale |
7.29 |
21,664 |
157,931 |
313,631 |
| Bergstrom Donald A | President, R&D |
Oct 28 '25 |
Sale |
7.29 |
30,897 |
225,239 |
521,823 |
2.09%
0.48%
자본화:
|
볼륨(24시간):